This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 750+ CE and professional development courses.

Goal and Learning Outcomes

Healthcare fraud is a crime. There are economic, financial, and legal impacts involved with fraudulent activity within the health system. Fraud has the potential to occur in any healthcare setting and it can be committed by anyone involved in the process, including clinicians, patients, or others. As a clinician, you are at the forefront for combatting fraud, and in a unique position to advocate for the patient. This course will help prepare you in recognizing and avoiding fraud within your own practice, as well as empower you in reporting suspicious activity.
The goal of this course is to equip clinicians with the knowledge of how to recognize, avoid, and report healthcare fraud.

Course Authors

4.7 Average

Course Reviews

1110 reviews

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.